Drug resistance is becoming more and more of a problem in treating HIV-1 infection, both because of the increasing number of patients who, having received long-term therapies, have developed resistance against most drugs, but also because of the now non-negligible possibility that a newlyinfected individual has been contaminated with an already resistant strain.
Most drugs used routinely inhibit either viral reverse transcriptase or protease. Resistance is gained through mutations in the genes coding for those proteins. Thus, sequencing the reverse transcriptase and protease genes theoretically allows us to predict which drugs will have reduced efficiency, and which will produce the best clinical benefit. Although the actual situation is not so clear-cut, sequencing of drug-targeted proteins' genes may shortly become an important virological tool for such cases as individuals with primary infection or pregnant women.
The number of mutations known to confer resistance is rapidly increasing, from 42 in 1994 to 143 in mid-1997 (Schinazi et al., 1997) . It is expected to increase steadily, as both recently introduced drugs and behavior of viruses outside clade B are being studied. Resistance due to combinations of mutations is also being documented. Manual analysis of raw viral sequence data is thus becoming both a very time-intensive and error-prone process.
Rather than a very specific program, we chose to develop a general tool that automates the search for given mutations in a set of sequences, and the evaluation of user-specified logical conditions about these mutations. We present here its application to the topic of HIV-1 genotypic resistance, with an emphasis on simplicity of use for the operator, and clarity of results, especially as support for clinical decisions.
Use of GRANT is straightforward: protein sequence data for a patient is pasted into a text file; each file has data for one patient only, but may contain several genes or gene fragments; amino-acid numbering is automatic. On running GRANT, the user is asked for complementary information such as patient name and sample date; an output file named after the patient is written (if duplicates exist, numerals are automatically appended to file names). This output, although printable as such, is meant to be used in conjunction with a companion program -GRANTOut -which produces fully typeset printouts. A sample output is given in Figure 1 .
GRANTOut is a Microsoft Excel macro, and thus requires Microsoft Excel 5.0 or higher to run. This allows for easy modification of the template printout sheets, and immediate integration into existing systems: no configuration steps are required.
Very little information is coded directly in GRANT; instead, most data are stored in external files, which can be edited with any text processor. Information is organized in independent sections.
On the most general level is the definition of proteins of interest: for each, a full name and an abbreviated name are specified, as well as expected sequence length -which can comprise several fragments, a sample sequence -which allows some degree of error tolerance, and the list of relevant drugs. Although most users will analyse protease and reverse transcriptase data, many will use their own primers; GRANT can readily be adapted to local set-up. Adding support for integrase sequence analysis is a simple matter of writing down a few lines of information in a new gene section.
Each drug is described in its own section, including resistance mutations definitions, and possible interpretations, which are defined as sets of logical expressions associated Fig. 1 . A sample typeset printout, showing only a reduced set of reverse transcriptase inhibitors. This example uses GRANT's tersest output: the nature of amino acid substitutions is not specified. Template printouts can be edited, for example to change laboratory names. The extent of sequenced regions is also printed as a reminder -here two fragments for reverse transcriptase -and omitted positions when sequences are shorter than expected.
with commentaries. As an example, when evaluating resistance to AZT, GRANT can be asked to check for the presence of mutations 215F/Y, 41L, 67N and 70R in combination, in which case it will comment that sensitivity to AZT is decreased over a hundred fold; bibliographic references may also be included in the commentary. The presence or lack of certain mutations can be specified with the logical operators 'and', 'or', and 'not'. Commentaries are printed when the specified conditions are met.
We provide a tool to aid the analysis of HIV-1 resistance genotypes. It does not require specific computer skills to operate, and can easily be made as exhaustive or as terse as required by each user. It is furthermore not HIV-specific, and can be used with any other organism, given the appropriate data files are constructed.
